Immunity Clinical Trials

3 recruiting

Frequently Asked Questions

Common questions about Immunity clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 118 of 18 trials

Recruiting

Understanding Immunity to the Flu Vaccine in COVID-19 Patients

ImmunityCorona Virus InfectionFlu Vaccine
Stanford University230 enrolled1 locationNCT04579588
Recruiting
Phase 4

Secukinumab Open Label Roll-over Extension Protocol

Autoimmunity, Inflammation
Novartis Pharmaceuticals1,000 enrolled167 locationsNCT04638647
Recruiting

VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older

Immunity, MucosalImmune System ProcessesBlood Specimen Collection
National Institute of Allergy and Infectious Diseases (NIAID)500 enrolled1 locationNCT01132859
Recruiting
Not Applicable

Effects of Bacillus Coagulans SNZ 1969 on Immune Health in Healthy School-aged Children

Immunity
Sanzyme Biologics Private Limited100 enrolled1 locationNCT07341750
Recruiting
Not Applicable

Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic Dermatitis

Atopic Dermatitis (AD)AutoantibodyAuto-Immunity+1 more
Universitair Ziekenhuis Brussel500 enrolled1 locationNCT07316465
Recruiting
Not Applicable

Neutralizing Power of Serum Antibodies - 2

COVID-19VaccinationMucosal Immunity+3 more
Centre Hospitalier Régional d'Orléans30 enrolled1 locationNCT07085611
Recruiting
Not Applicable

The Use of Cytomegalovirus Cell Mediated Immunity to Optimize the Duration of Letermovir Prophylaxis in Hematopoietic Cell Transplant Recipients

Hematopoietic Cell TransplantCytomegalovirus Cell Mediated Immunity
M.D. Anderson Cancer Center105 enrolled1 locationNCT06639854
Recruiting

Early Life Malnutrition, Environmental Enteric Dysfunction and Microbiome Trajectories

Environmental Enteric DysfunctionMalnutrition in ChildrenMalnutrition (Calorie)+10 more
University of Zimbabwe368 enrolled1 locationNCT07195006
Recruiting
Not Applicable

Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Malignant Tumor

Tumor Immunity
Peking Union Medical College Hospital50 enrolled1 locationNCT06844110
Recruiting
Phase 1

First-time-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RB201 in Healthy Adult Subjects

autoimmunity
Rarefied Biosciences Australia PTY LTD88 enrolled1 locationACTRN12625000694415
Recruiting

To Evaluate Mucosal and Systematic Immune Response to Acute Respiratory Tract Infections of South African Children

Mucosal ImmunityRespiratory Tract Infections (RTI)
Desmond Tutu TB Centre250 enrolled2 locationsNCT06902194
Recruiting

Immunodysregulation As an Expression of Underlying Inborn Errors of Immunity: Implementation of Diagnostics and Management of Pediatric and Adult Patients with Immune System Disorders

Inborn Errors of Immunity
IRCCS Azienda Ospedaliero-Universitaria di Bologna400 enrolled1 locationNCT06773546
Recruiting

Characterization of Human Immune Signatures to Zoonotic Virus Exposure in Cambodia

Immunity, Humoral
National Institute of Allergy and Infectious Diseases (NIAID)400 enrolled5 locationsNCT06680843
Recruiting
Not Applicable

Lung Immune Challenge Study: Controlled Exposure to Inhaled Resiquimod (R848)

AsthmaViral InfectionInnate Immunity+1 more
Akhilesh Jha36 enrolled1 locationNCT06488118
Recruiting

Restoration of Immunity to Vaccine Preventable Diseases After CART-T Cell Therapy

Vaccine Immunity in CAR-T Cell Therapy Recipients
Insel Gruppe AG, University Hospital Bern80 enrolled1 locationNCT06333275
Recruiting
Phase 2

PTCy and and Ruxolitinib for GVHD Prophylaxis After HSCT With Thymoglobulin in Conditioning Regimen in Patients With Inborn Errors of Immunity

Inborn Errors of Immunity
Federal Research Institute of Pediatric Hematology, Oncology and Immunology100 enrolled1 locationNCT06199427
Recruiting
Phase 2

RFA Plus Carrizumab vs Carrizumab Alone for HCC

Radiofrequency AblationTumor ImmunityImmunosuppression
Second Affiliated Hospital, School of Medicine, Zhejiang University120 enrolled1 locationNCT04150744
Recruiting

Hepatitis B immunity and response to a booster dose of hepatitis B vaccine in Indigenous children who recieved hepatitis B vaccines in infancy

Hepatitis B immunity in healthy subjects
National Centre for Immunisation Research and Surveillance450 enrolled1 locationACTRN12606000396527